Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benfotiamine + alpha-lipoic acid is a combination dietary supplement that promotes normal glucose metabolism and provides antioxidant support. Benfotiamine is a highly bioavailable, synthetic derivative of thiamin (vitamin B1) that can influence biochemical pathways to support the circulatory and nervous systems. Alpha-lipoic acid (ALA) is known as the "universal antioxidant" due to its solubility in both water and fat. It functions as a coenzyme in the energy-producing Krebs cycle and has the capacity to impact cardiovascular, ocular, and brain health. This combination helps maintain healthy cells in the presence of circulating glucose, provides support against oxidative stress, and supports healthy aging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benfotiamine + alpha-lipoic acid.